JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kido, S.
Right arrow Articles by Takeda, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kido, S.
Right arrow Articles by Takeda, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 40, 28256-28263, October 1, 1999


Identification of Regulatory Sequences and Binding Proteins in the Type II Sodium/Phosphate Cotransporter NPT2 Gene Responsive to Dietary Phosphate*

Shinsuke KidoDagger , Ken-ichi MiyamotoDagger §, Hiroyuki Mizobuchi, Yutaka TaketaniDagger , Ichiro OhkidoDagger , Nobuo Ogawa, Yoshinobu Kaneko, Satoshi Harashima, and Eiji TakedaDagger

From the  Laboratory of Molecular Genetics, Department of Biotechnology, Graduate School of Engineering, Osaka University, Yamadaoka 21-1, Suita City, Japan and the Dagger  Department of Clinical Nutrition, School of Medicine, Tokushima University, Kuramoto-Cho 3, Tokushima City 770, Japan

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Dietary phosphate (Pi) is a most important regulator for renal Pi reabsorption. The type II sodium-dependent phosphate (Na/Pi) cotransporters (NPT2) are located at the apical membranes of renal proximal tubular cells and major functional transporters associated with renal Pi reabsorption. The consumption of a low-Pi diet induces the synthesis of NPT2, whereas a high Pi diet decreases it. The molecular mechanisms of regulation by dietary Pi are not yet known.

In this report, in weaning mice fed a low-Pi diet for 4 days, the NPT2 mRNA level was increased 1.8-fold compared with mice fed a normal Pi diet. This increase was due to an elevation of the transcriptional activity. In the NPT2 gene promoter, the DNA footprint analysis showed that six regions were masked by the binding protein, but at the position -1010 to -985 upstream of the transcription start site, the binding clearly responded to the levels of dietary Pi. The phosphate response element (PRE) of the NPT2 gene was found to consist of the motif related to the E box, 5'-CACGTG-3'. A yeast one-hybrid system was used to clone a transcription factor that binds to the PRE sequences in the proximal promoter of the NPT2 gene. Two cDNA clones that encoded protein of the mouse transcription factor µE3 (TFE3) were isolated. This is a DNA-binding protein that activates transcription through the µE3 site of the immunoglobulin heavy chain enhancer. TFE3 antibody completely inhibited the binding to the PRE. The coexpression of TFE3 in COS-7 cells transfected with the NPT2 gene promoter markedly stimulated the transcriptional activity. The feeding of a low Pi diet significantly increased the amount of TFE3 mRNA in the kidney. These findings suggest that TFE3 may participate in the transcriptional regulation of the NPT2 gene by dietary Pi.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The regulation of inorganic phosphate (Pi)1 in the human body is controlled mainly by reabsorption in the proximal tubules of the kidneys (1-3). Apical Na+-dependent phosphate (NaPi) cotransport is central to the renal proximal tubular reabsorption of Pi (2, 3). Studies of isolated kidney tubules and of brush-border membranes have demonstrated that the physiological regulation of proximal tubule Pi transport involves complex hormonal and metabolic factors that affect the activity or expression of the transporter molecules (1-3). A major regulator of the NaPi cotransporter is dietary Pi (4-7). Dietary Pi restriction is associated with an adaptive increase of the overall proximal tubular capacity to reabsorb Pi (4-7). Alterations of the dietary intake of Pi lead to an adaptation of renal Pi transport activity independent of extrarenal factors such as parathyroid hormone, growth hormone, and vitamin D (1-3, 9, 10). The molecular mechanisms of this adaptation are unknown.

Three types of Na+-dependent Pi cotransporter have been isolated from a kidney library (11, 12). Recent studies suggest that the type II transporters (NPT2) may play an important role in Pi homeostasis in the kidney, that they are controlled by parathyroid hormone, and by the dietary intake of Pi (11-13). In a previous study, we investigated the cellular mechanism of the up-regulation of the NaPi cotransporter in mice induced by the intake of a low Pi diet and found that the administration of a low Pi diet to the mice clearly stimulated the elevation of NPT2 mRNA and protein (7). We have been studying the NPT2 gene expression using dietary Pi feeding in mice. The NPT2 genes respond at the transcriptional and post-transcriptional level to an increased Pi concentration in the diet (6, 7). The DNA sequences responsible for the Pi response in the mouse kidney, which we have designated the phosphate response elements (PRE), have been mapped. The PRE of the NPT2 gene promoter shares a region with 9 of 10 bp identity to yeast phosphate-responsive transcription factor Pho4 binding element. At the center of this region is a CACGTG motif, the core recognition site for the helix-loop-helix of transcription factors. This segment contains a 5'-CACGTG-3' motif that is sufficient to confer the transactivation by dietary Pi deprivation. We also isolated a transcription factor (a helix-loop-helix protein), which has structural features very similar to those of yeast Pi regulon Pho 4.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Animals and Diets-- Male ICR mice (3 weeks after birth) were purchased from SLC (Shizuoka, Japan). They were housed in plastic cages and the animals were fed standard mouse chow (Oriental, Osaka, Japan) ad libitum. For the first week, they were fed the diet. After the period, they received a diet containing 1.2% calcium, 0.6% phosphorus and 4.4 IU vitamin D3/g for 5 days. Thereafter, they were fed a diet with a normal Pi level (0.6%) for 7 days, given between 11:00 a.m. and 1:00 p.m. (6, 7). On the 8th day, the following three groups of six mice each were established the normal Pi group, mice that were chronically fed a diet containing 0.6% Pi; the low Pi group, mice that received a diet containing a low percentage (0.02%) of Pi; and the high Pi group, in which the mice received a high percentage (1.2%) Pi diet. After 4 days of the given diet, all of the mice were anesthetized with intraperitoneal pentobarbital, and the kidneys were rapidly removed. One-half of each kidney was used for RNA isolation and the other half was used for the isolation of brush-border membrane vesicles (7).

Northern Blot Analysis-- Total RNA was isolated from the kidney by extraction with acid guanidine thiocyanate/phenol/chloroform using the method of Chomczynski et al. (13). A NaPi-7 cDNA probe (2.4 kilobase pairs) was obtained from a mouse kidney cDNA library (5). The internal standard was GAPDH cDNA.

Cloning of DNA-binding Proteins Using the Yeast One-hybrid System-- A reporter gene, NPT2 PRE-CYC1-HIS3, for yeast one-hybrid study (14) was constructed as follows. The Saccharomyces cerevisiae HIS3 coding region connected downstream of the UAS (upstream activating sequence)-less S. cerevisiae CYC1 promoter was constructed on a pUC19-based plasmid containing the S. cerevisiae ADE2 gene fragment. This plasmid was designed as pCHNaPi0. The five tandem copies of 36-bp double-stranded oligonucleotide, which originates from the sequences corresponding to the nucleotide positions from -1010 to -985 in human NPT2 promoter, including PRE, were inserted into upstream of the CYC1 promoter on pCHNaPi0 as its UAS sequences. The resulting plasmid, pCHNaPi5, was integrated into a ade2 locus on chromosome of S. cerevisiae strain HYP100 (MATa ura3-52 leu2-3,112 trp1Delta his3Delta ade2-101 lys2-801; our stock strain), and this integrant strain was designated as YBH5. The other yeast strain YBH0 was constructed by the similar integration using pCHNaPi0 instead of pCHNaPi5.

More than 2 × 106 colonies of YBH5 transformants by mouse kidney cDNA library (mouse kidney MATCHMAKER cDNA, CLONTECH Inc., Palo Alto, CA) were screened by their growth on the histidine omission plates with 30 mM of 3-amino-1,2,4-triazole as described in the CLONTECH manual. Eighty-five of positive colonies were obtained on the original plates, and two colonies out of them showed reproducible phenotypes on the above condition. Plasmids carrying the cDNA clones were obtained by extraction from the two yeast transformants as described (15) followed by transformation of E. coli.

Reporter Plasmid Construction-- A 2450-bp BamHI-EcoRI DNA fragment containing the 5'-flanking region of the NPT2 gene was subcloned into pBluescript II SK(+) (16). A BamHI-HindIII fragment from the resulting plasmid was then subcloned upstream of the coding region of the luciferase gene in the vector Pica-Basic (Toyo Ink, Tokyo, Japan) to generate the reporter plasmid p3P2400. Mouse transcription factor µE3 (TFE3) expression vectors were constructed by subcloning on an EcoRI DNA fragment containing the full-length TFE3 cDNA into pcDL-SRalpha -296 (kindly provided by N. Arai) (17). The internal control vector pCMVbeta , which expresses beta -galactosidase, was obtained from CLONTECH. Each plasmid was purified with a plasmid kit (Qiagen, Hilden, Germany).

Cell Culture and Transient Transfection-- COS-7 cells (Riken Cell Bank, Tokyo) were cultured at 37 °C and under 5% CO2 in Dulbecco's modified Eagle's medium (Sanko-junyaku, Tokyo) with 10% fetal bovine serum (Sigma). OK cells (ATCC:CRL1840) were maintained in F-12/Dulbecco's modified Eagle's medium (1:1, v/v) containing 10% fetal bovine serum (16). Cells were transfected using the DEAE-dextran method with 5 µg of the NPT2 gene promoter-luciferase reporter plasmid, 0.5 µg of mouse TFE3L, or TFE3S expression plasmid and 5 µg of pCMVbeta per 5 × 105 cells, as described previously (16-18). After transfection, the cells were incubated under standard conditions for 48 h and then exposed to various agents for 15 h. Cells were then harvested in cell lysis buffer, and the lysate was assayed for luciferase activity, beta -galactosidase activity, and protein concentration (19).

Electrophoretic Mobility Shift Assay (EMSA) and DNase Footprint Assays-- Nuclear extracts were prepared from kidney or COS-7 cells as described previously (9). The 32P-labeled -1045 to -1035 probe and wild-type and mutant promoter probes were purified from a nondenaturing acrylamide gel. EMSA was carried out as described previously (9) with the following modifications. The binding buffer for the probes was 4 mM HEPES, pH 7.9, 10% glycerol, 50 mM KCl, 50 µM EDTA, and 0.1 mM dithiothreitol, and the gel was run in a low ionic strength buffer (6.4 mM Tris, pH 7.5, 3.3 mM sodium acetate, and 1 mM EDTA) at room temperature. Supershift assays were carried out as described previously (9) using available antibodies to TFE3 from Dr. K. Calame (20). A DNase I footprinting analysis was performed using a commercial kit (SureTrac Footprinting Kit, Amersham Pharmacia Biotech, Uppsala, Sweden).

Shift-Western Blotting-- Shift-Western blotting was performed according to the method of Demczuk et al. (21). This method was developed for identification and analysis of protein and DNA components of gel-shift assays. Approximately 20 µg of nuclear protein was used in a preparative gel shift. After transfer onto DE81 paper, the protein-DNA complexes were identified by autoradiography. Proteins were eluted from excised filter pieces with 0.4 M acetic acid, 1 M NaCl at 65 °C for 40 min and then precipitated for 30 min with 10% cold CCl3COOH, washed once in acetone and twice in cold 100% ethanol, vacuum-dried, resuspended, denatured in sample buffer, and subjected to SDS/10% polyacrylamide gel electrophoresis and Western blotting (21).

Nuclear Run-on Transcription Assay-- Nuclei were prepared from the kidney of mice fed a low Pi diet, and nuclear run-on transcription assays were performed as described previously (22). RNA was extracted and resuspended in 300 µl of hybridization buffer (7% SDS, 10% polyethylene glycol (8,000), 1.5% saline/sodium phosphate/EDTA). Aliquots of RNA from treated and untreated samples were counted in a scintillation counter, and an equal number of counts from each condition (1-2 × 106 cpm) were hybridized to linearized cDNAs (5 µg) for NPT1, NPT2, GAPDH, pBluescript II DNA, which were immobilized to Hybond filters using a slot blot apparatus.

Stastical Analysis-- Data are expressed as the mean ± S.E. Differences between experimental groups were determined by analysis of variance, and p values < 0.05 were accepted as indicating a significant difference.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Effects of Low Pi Diet on the Expression of the Type II Transporter Gene-- The brush-border membrane vesicles isolated from renal proximal tubules of mice fed a diet low in Pi for 4 days were prepared and used for the assay of Pi transport activity. The analysis of the Na+-dependent Pi uptake at 1 min revealed an approximately 1.7-fold increase in these mice compared with mice that received a control Pi diet (p < 0.01) (Fig. 1A). As shown in Fig. 1B, the NPT2 mRNA levels were significantly increased (by about 1.8-fold) in the mice fed the low Pi diet for 4 days. In addition, the amounts of the NPT2 protein (the 80-90-kDa bands) were significantly increased (by about 2.5-fold for the 90-kDa band) compared with those in mice fed the control diet (Fig. 1C). In contrast, the high Pi diet significantly suppressed these three parameters (transport activity, mRNA, and protein).


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 1.   Effects of dietary Pi on Pi transport activity, type II transporter mRNA, and protein levels in mouse kidney. brush-border membrane vesicles were isolated from mice fed the test diet (a low Pi diet (LP), a normal Pi diet (CP), or a high Pi diet (HP)) for 4 days. Na+-dependent Pi transport activity (A) and the amounts of NPT2 protein (C) were determined as described under "Experimental Procedures." The levels of NPT2 mRNA were determined using Northern blot analysis (B). The density of the signals was measured using an imaging analyzer (Fuji-BAS2000). The relative intensity was based on the control mRNA (GAPDH). *, p < 0.01. The data are mean ± S.E. of six mice per group. D, in vitro transcription in isolated nuclei of renal cells from mice fed the low Pi diet. Nuclei were isolated from the renal cortex of mice fed a normal Pi diet (CP), or 4 days after the change to a low Pi diet (LP), and were assayed for transcription in vivo. 32P-Labeled transcripts were hybridized to NPT1, NPT2, and GAPDH cDNA. Lane CP, the normal Pi diet; lane LP, the low Pi diet.

We studied the in vitro transcription in isolated nuclei of renal cortex cells from mice fed the low Pi diet. As shown in Fig. 1D, the transcriptional activity in the NPT2 is significantly increased in the mice fed the low Pi diet compared with those in the mice fed the control Pi. The transcriptional activity of the type I NaPi cotransporter NPT1 gene was not significantly different between the normal Pi and low Pi groups. Thus, the elevation (1.8-fold) of the NPT2 mRNA levels in the mice fed the low Pi diet was, at least in part, due to the increase in the transcription of the NPT2 gene.

An E Box at -1010 to -985 Plays an Important Role in the Response to Dietary Pi-- To clarify the protein binding region in the NPT-2 gene promoter induced by the feeding of a low Pi diet, we performed DNase footprint assays using nuclear extracts from the renal cortex isolated from mice fed a low Pi diet (Fig. 2). The footprints in the nuclear extract isolated from mouse renal proximal tubular cells had a series of hypersensitive sites in common and a protected region extending from -2018 to -1996 nt (FP-1), -1556 to -1535 nt (FP-2), - 1010 to -985 nt (FP-3) nt relative to the transcription start site of the NPT2 gene that may indicate the binding of a factor in mouse kidneys (Fig. 2). There was also additional protection within the regions of -779 to -757 nt (FP-4), -635 to -612 nt (FP-5) and -321 to -298 nt (FP-6), indicating that an additional factor binds the DNA in mice kidney (data not shown). In the comparison of these elements between the mice fed the low Pi and high Pi diets, we found that the extent of the protection at -1010 to -985 nt (FP-3) was significantly different between these two groups of animals (Fig. 3A). However, the other protected regions were not changed by the deprivation of dietary Pi (data not shown). We designed the FP-3 position as PRE.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 2.   In vitro DNase I footprint analysis in NPT2 promoter. The NPT2 gene fragments were incubated with DNase I and 20 µg of kidney extracts isolated from mice fed a low Pi diet. Nucleotide sequence of a portion of NPT2 and exon 1. Footprints are underlined by a black bar (FP-1 to FP-6). The major transcription start site is marked by an arrow.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Effect of dietray Pi on DNase I footprinting with renal cortex nuclear extracts. A, the NPT2 gene fragment (FP-3) was incubated with DNase I and 20 µg of kidney extracts isolated from mice fed either a low Pi diet (lanes 1 and 2), those fed a normal Pi diet (lane 4), or those fed a high Pi diet (lanes 5 and 6). The number is the location of the protected regions by DNase footprinting analysis. Lane 3, no nuclear extract. B, the proximal NPT2 promoter sequences and the location of PRE. The lower panel indicates the sequences of oligonucleotides for EMSA in Fig. 4.

Mutation Analysis of the PRE Sequence of the NPT2 Gene Promoter-- Next, we used the oligonucleotide of PRE (-1010/-985 nt) and performed EMSA. In nuclear extract isolated from mice fed a low Pi diet, the increased DNA-protein complex was observed in EMSA (Fig. 4), but the increase in the DNA/protein complex was not observed with FP-1, FP-2, FP-4, FP-5, and FP-6 probes (data not shown). The protein-DNA complex was completely inhibited unlabeled PRE oligonucleotide.


View larger version (59K):
[in this window]
[in a new window]
 
Fig. 4.   Characterization of nuclear protein binding to PRE. A, EMSA of the 25-bp PRE-WT sequence. Nuclear extracts were prepared from the kidneys of mice fed a low Pi (LPD) or normal Pi diet (CPD). The competitor used was a wild-type sequence of 25 bp of PRE oligonucleotide (PRE-WT). B, EMSA of wild-type PRE and mutations (PRE-MT1, PRE-MT2, and PRE-MT3). Mice kidney nuclear extracts were used in these assays to assess the effects of mutations in the PRE (the E box) sequence on DNA-protein interaction. Oligonucleotides that corresponded to the E box element were synthesized as described under "Experimental Procedures." The results of competition experiments are shown in the lanes with the triangles, with the competing oligonucleotide indicated above the triangle. The competitors were added 25-(×25), 50-fold (×50), and 100-fold (×100) in the EMSA. The data presented are representative of three independent experiments.

Interestingly, the sequence of PRE was very similar to those of the Pi responsible element for the promoter of the Pi transporter gene PHO84 and acid phosphatase gene PHO5 in yeast (23). This element is known to be a Pho4 binding site. Pho4 is a helix-loop-helix transcription factor for the genes associated with yeast Pi metabolism and binds the E box sequence 5'-CACGTG-3'. To confirm that the E box sequence is the target sequence of the putative binding protein, we performed EMSAs with oligonucleotides containing specific mutations of this sequence (Fig. 3B). The PRE-MT1 oligonucleotide, in which GG in the 5' half-site of the PRE sequence was changed to TT, showed binding activity similar to that of the PRE-WT (Figs. 3B and 4B). The mutation of TG in the E-box to AA (PRE-MT2) abolished the ability to interact with PRE-WT (Fig. 3B). Mutation of the second and third nucleotides (PRE-MT3) of the E-box also abolished the binding activity (Fig. 4B), suggesting that the putative binding protein recognized the sequence 5'-CACGTG-3' in the promoter of the NPT2 gene.

Functional Role of PRE in the NPT2 Promoter-- We investigated the role of the PRE in the basic promoter activity of the NPT2 gene. The vector (p3P1170) was constructed with the NPT2 gene promoter (-1289 to +54 nt), which contains the PRE (-110/-985 nt), linked to the luciferase reporter gene in OK cells. Transfection of p3P1170 into OK cells showed a 6-fold increase in the activity of control vector-transfected OK cells. Mutation of the E box in the PRE (p3P1170MT) markedly decreased the basic promoter activity, suggesting that the PRE is important for the expression of the NPT2 gene in OK cells (Fig. 5).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Mutation of the PRE in the NPT2 gene promoter. OK cells were transfected with luciferase reporter genes constructed with the wild-type (p3P1170WT) or the indicated mutation (p3P1170MT) of the NPT2 promoter. Luciferase activity was determined as described previously (19). Each bar represents the mean ± S.E. of five independent transfections.

Relationship between Plasma Pi Levels and PRE Binding Activity-- To further analyze whether the binding activity in the PRE is regulated by plasma Pi concentration, we measured plasma Pi levels and PRE binding activity in the nuclei isolated from mice fed a low Pi, normal Pi, or a high Pi diet. As shown in Fig. 6, the binding activity in the PRE-WT oligonucleotide decreased in parallel with the elevation of plasma Pi levels. There was a good correlation with both parameters (PRE binding activity and plasma Pi concentration).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 6.   Relationship between the PRE binding activity and serum Pi concentration. The PRE binding activity were measured in nuclei isolated from mice fed a high Pi, a normal Pi, or a low Pi diet. Nuclear extracts were prepared from the kidneys of mice fed a low Pi for 3 days, control Pi diet for 5 days, or a high Pi diet for 8 days. Serum Pi concentration was measured as described previously (7). The binding activity was measured by densitometric analysis. Data represent a relative activity for the binding activity of the nuclei isolated from normal diet fed mouse (serum Pi = 6.4 mg/dl).

Cloning of PRE-binding Protein by the Yeast One-hybrid System-- To begin to identify some of the proteins that bind this segment, we used this DNA (nucleotide positions from -1010 to -985) as a UAS of the reporter gene's promoter in the yeast one-hybrid system and screened a mouse kidney cDNA library. The yeast strain YBH5 is histidine auxotroph and 3-amino-1,2,4-triazole-sensitive phenotypes depending on the expression of the reporter gene, NPT2 PRE-CYC1-HIS3 on its chromosome. More than 2 × 106 colonies of YBH5 transformants by mouse kidney cDNA library which produced fusion proteins between cDNA-encoding protein and the transcriptional activation domain of GAL4 were screened. Two positive colonies reproducibly showed histidine prototroph and 30 mM 3-amino-1,2,4-triazole resistance phenotypes. The plasmids obtained from the two colonies didn't give histidine prototrophy phenotype to YBH0 strain which has a UAS-less CYC1-HIS3 reporter gene on its chromosome instead of NPT2 PRE-CYC1-HIS3. It was speculated that the cDNA on the two plasmids encode the binding proteins to the NPT2 PRE sequence on the reporter gene.

One cDNA contained an almost full-length coding sequence for TFE3 and the other was a shorter partial cDNA for TFE3. TFE3 is a DNA-binding protein that activates transcription through the µE3 site of the immunoglobulin heavy chain enhancer (17, 18). To isolate the functional TFE3 full-length cDNA clone, we screened the mouse kidney cDNA library (from mice fed a low Pi diet). We isolated TFE3L and TFE3S cDNA clones. The full-length TFE3 was termed TFE3L, and TFE3S is the isoform for the TFE3L and is truncated at the N-terminal region (transactivation domain) of TFE3L (32) (Fig. 7A).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 7.   Transfection analysis of TFE3L and TFE3S. A, schematic representation of TFE3L and TFE3S. We isolated clones that encoded two isoforms of mTFE3. The mTFE3S mRNA encodes a polypeptide of 291 amino acids, whereas the mTFE3L mRNA encodes a polypeptide of 326 amino acids. AAD, acid activation domain; HLH-LZip, a helix-loop-helix region and DNA binding region; Pro-rich, proline-rich domain. B, COS-7 cells expressing TFE3L or TFE3S were cotransfected with the luciferase reporter gene constructed with the wild-type (p3P1170WT) or the indicated mutation (p3P1170MT; the position and nucleotide in the mutation are identical to the MT-3) of the NPT2 gene promoter. Results are expressed as relative activity of p3P1170WT vector or p3P1170MT vector, respectively. The data presented are the means ± S.E. of five experiments.

Functional Analysis of the Effects of TFE3L and TFE3S on the Transactivation of the NPT2 Gene Promoter-- To determine whether TFE3 can activate the transcription of the NPT2 gene, the TFE3L cDNA was cloned in a mammalian expression vector, and the vector was cotransfected with the NPT2 gene promoter (-1289 to +54) linked to the luciferase reporter gene (p3P1170WT) in COS-7 cells. TFE3L stimulated the luciferase activity 6-fold compared with that of the control vector (Fig. 7B). TFE3S also stimulated the transcription (2.8-fold). TFE3L induced the luciferase activity in the COS-7 cells transfected with the NPT2 gene promoter with the mutation of the PRE (p3P1170MT), but the induction was lower compared with that in the p3P1170WT clone (Fig. 7B).

Binding of TFE3 to the PRE-- To further confirm the specific binding to TFE3L and TFE3S in the promoter of the NPT2 gene, EMSAs were performed using a 32P-labeled -1010 to -985 oligonucleotide as a probe (PRE-WT) and several competitor DNA oligonucleotides (PRE-MT1, PRE-MT2, and PRE-MT3) corresponding to the E box (Fig. 8). In this experiment, the mouse TFE3L expression vector was transfected into COS-7 cells, and the nuclear extract expressing mouse TFE3L was used for EMSA. The PRE-WT oligonucleotide was in competition for the binding. In addition, the PRE-MT1 oligonucleotide partially prevented the binding. The PRE-MT2 and PRE-MT3 oligonucleotides were unable to compete for the DNA-protein binding (Fig. 8, lanes 4 and 5). In addition, TFE3-specific antibodies completely prevented the DNA-protein binding in an EMSA (Fig. 8, lane 6). It suggests that TFE3 protein bound to the -1010 to -985 oligonucleotide.


View larger version (47K):
[in this window]
[in a new window]
 
Fig. 8.   Effect of TFE3 antibody on the binding of PRE in the nuclear extract isolated from the kidney cortex of the mice fed a low Pi diet. A, EMSA with various PRE sequence as shown in Fig. 3B. EMSA with nuclear extracts from COS-7 cells transfected with expression vector for mouse TFE3L. The PRE-MT1, PRE-TM2, and PRE-MT3 oligonucleotides were the same in those shown Fig. 4, and their sequences are given in Fig. 3B. The antiserum of mouse TFE3 (2 µl) was added to the binding reaction mixture before the addition of the radiolabeled oligonucleotide (20). Lane 1, PRE-WT; lane 2, added cold PRE-WT (×25); lane 3, added PRE-MT1 oligonucleotide (×25); lane 4, added PRE-MT2 oligonucleotide (×25); lane 5, added PRE-MT3 oligonucleotide (×25); lane 6, 2 µl of TFE3 antibody. B, shift-Western analysis of the protein-DNA complex. The protein-DNA complexes, separated in polyacrylamide gels, were transferred onto stacked nitrocellulose and anion-exchange membranes. The proteins bound to nitrocellulose were identified by immunoblotting by TFE3-specific antibody (lane 2), while the DNA, which bound only to the anion-exchange membrane, was detected by autoradiography (lane 1). Nuclear proteins were prepared from the kidneys of mice fed a low Pi diet. C, effect of TFE3 antibody on nuclear protein binding to PRE. The nuclear extract from kidney cortex of mice fed a low Pi diet incubated with 32P-labeled PRE-WT oligonucleotide. The TFE3 antibody was added to EMSA reaction medium. Lane 1, DNA protein complex in EMSA; lane 2, added TFE3 antibody.

To further confirm that the DNA-binding protein is TFE3, we performed the shift-Western analysis. The nuclear extract isolated from mice fed a low Pi diet was incubated with 32P-labeled PRE oligonucleotide and then performed the shift-Western analysis (Fig. 8B, lanes 1 and 2). This method was developed for identification and analysis of protein and DNA components of gel-shift assays. The protein-DNA complexes, separated in polyacrylamide gels, were transferred onto stacked nitrocellulose and anion-exchange membranes. The proteins bound to nitrocellulose were identified by immunoblotting (Fig. 8B, lane 2), while the DNA, which bound only to the anion-exchange membrane, was detected by autoradiography (Fig. 8B, lane 1).

This experiment clearly indicated that the DNA binding protein is TFE3. Moreover, we determined whether TFE3 antibody inhibits the binding of PRE-WT and renal nuclear extract isolated from mice fed a low Pi diet. As shown in Fig. 8C, TFE3 antibody completely blocked the binding of PRE-WT and the nuclear protein (Fig. 8C, lane 2).

Expression of TFE3 mRNA-- To further clarify the role of TFE3 on the expression of mouse NPT2, the amounts of TFE3 mRNA were determined in the kidney of the mice fed a low Pi diet. The levels of TFE3 mRNA were markedly increased 12 h after mice were changed to the low Pi diet and had slightly decreased by 72 h (Fig. 9A). At 72 h, the levels of TFE3 mRNA was 2.1-fold the control (zero time) (Fig. 9B). In contrast, the levels of mouse NPT2 mRNA were increased at 48 h and significantly elevated at 72 h.


View larger version (35K):
[in this window]
[in a new window]
 
Fig. 9.   Time course of TFE3 and NPT2 mRNA expression in mice fed a low Pi diet. A, mice were fed a diet with a normal Pi level (0.6%) for 7 days, given between 11:00 a.m. and 1:00 p.m. On the 8th day, mice received a diet containing a low percentage (0.02%) of Pi. At 0, 12, 24, 48, and 72 h after receiving the diet, total RNA (20 µg) was prepared as described under "Experimental Procedures." Northern blot analysis was performed using mouse TFE3 and NPT2 cDNA probes. The intensity of each hybridization was normalized to the GAPDH mRNA. Data represent means ± S.E. of five animals. B, Northern blot analysis of TFE3 mRNA. Lane 1, 0 h; lane 2, 12 h; lane 3, 24 h; lane 4, 36 h.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Chronic dietary Pi restriction leads to an increased NaPi cotransport rate, along with increased NPT2 protein and mRNA (3-8). In the present study, the transcription rate was significantly increased in nuclei isolated from the kidney cortex of mice fed the low Pi diet. Recent reports suggest that the up-regulation is due to the elevation of the type II transporter synthesis by Pi deprivation and is the elevation of the stability for the type II transporter mRNA, but not transcription (24, 25). However, in the present study, we concluded that the elevation of the NPT2 mRNA level is due, at least in part, to an increase in the transcription rate. The difference in the findings of run-on assay may be based on the feeding schedule or animal age, because our feeding schedule used meal feeding. In this schedule, the animals can feed only during one period of 2 h in a day. This schedule is useful to investigate the effect of dietary Pi on the regulation of NPT2 synthesis (6). In the low Pi group, the plasma Pi levels were suddenly decreased compared with those in the normal Pi group. When the animals were fed a low Pi diet ad libitum, the plasma Pi levels were gradually decreased. The differences of the feeding schedule might have affected the regulation of NPT2 in the kidney.

In a nuclear run-on assay, we analyzed the four marker genes used: neutral basic amino acid transporter (NBAT), peptide transporters (PepT1), type I NaPi cotransporter (Npt1), and GAPDH (data not shown). In these conditions, we clearly found that all cDNA did not respond to dietary Pi in a run-on assay. We also observed the increase in the stability of the NPT2 transcripts in vitro assay (26). This step may also be an important regulatory point as proposed by the Murer and Ghishan studies (24, 25).

The present DNA footprinting analysis showed that six regions of the NPT2 gene promoter were masked by the nuclear protein isolated from the mice fed a low Pi diet. In addition, the gel-shift mobility assay demonstrated that the binding for the element was markedly increased in the nuclei isolated from the kidney cortex of the mice fed the low Pi diet. This binding protein recognized the consensus sequence 5'-CACGTG-3' known as the E box. The PRE of the NPT2 gene was further investigated by EMSA with various oligonucleotides as probes and competitors.

Interestingly, the sequence of the PRE was very similar to those in the Pi-response element for the promoter of the Pi transporter gene PHO84 and acid phosphatase gene PHO5 (23, 27, 28) in the yeast S. cerevisiae. This element is known to be a Pho4 binding site. Pho4 is a helix-loop-helix transcription factor for the genes associated with yeast Pi metabolism (23, 27, 28). An EMSA demonstrated the formation of two complexes between oligonucleotides containing PRE and nuclear extract. The binding of the sequence with isolated nuclei was detected in the mice fed the low-Pi diet, but not in those fed the normal diet. The formation of the protein-DNA complex was inhibited in the presence of an oligonucleotide containing the Pho4 binding site of the yeast PHO84 gene promoter.

We isolated cDNAs for the protein TFE3L/S by the yeast one-hybrid system. The coexpression of TFE3 markedly stimulated the promoter activity in the NPT2 gene, but not in the NPT2 gene with the mutation sequence in the E box. This suggested the possibility that TFE3L/S might bind specifically to the -1010 to -985-bp segment of the human NPT2 gene in Pi deprivation. Indeed, the incubation with antibodies for mouse TFE3 completely inhibited DNA/nuclear protein binding, suggesting that protein-DNA complex in EMSA using the renal nuclear extract are TFE3.

In addition, we identified a similar PRE in the NPT2 gene of opossum kidney (29) cells. The similar sequences are located at position -2453 to -2441 relative to the transcription start site of the opossum NPT2 gene promoter. The sequence is 5'-CACNNTGC-3', and TFE3 can bind this E box sequence. In addition, 25-hydroxyvitamin D3 1alpha -hydroxylase (1alpha -hydroxylase) catalyzes hydroxylation, mainly in the kidney, of 25-hydroxyvitamin D3 into 1alpha ,25-dihydroxyvitamin D3, a hormonal form of vitamin D, acting as a key enzyme of vitamin D biosynthesis (30). Dietary Pi restriction increases 1alpha -hydroxylase activity, while high Pi diet decreases it (31). In the mouse and human 1alpha -hydroxylase gene promoters, the similar sequence is located at position -660 to -655 relative to the transcription start site of the mouse 1alpha -hydroxylase gene (32, 33). It is possible that the PRE sequence in the 1alpha -hydroxylase gene promoter may also be important for dietary Pi regulation (data not shown). To further clarify the role of the PRE in the NPT2 gene promoter, we are now cloning mouse and rat NPT2 gene promoter.

What is the nature of the Pi-responsive factor? Factors binding to the CACGTG motif have been shown to belong to the c-Myc family. While many members of this family have been identified, TFE3 is the predominant factor in renal extracts that binds to the PRE in vitro. A recent study demonstrated that the TFE3 gene was a candidate for papillary cell carcinoma (34), suggesting that the gene may function as the tumor repressor in renal cells. In addition, Hua et al. (35) reported that TFE3 is an important transcription factor in at least one TGF-beta -activated signal transduction pathway. TGF-beta is known to have widespread regulatory effects on extracellular matrix and has been implicated as a major cause of increased extracellular matrix synthesis and buildup of pathological matrix within glomeruli in experimental glomerulonephritis (36). A mechanism of the rapid therapeutic effect of a low protein diet on experimental glomerulonephritis is through suppression of TGF-beta expression and prevention of the induction of extracellular matrix synthesis within the injured glomeruli (36). It is possible that TFE3 regulated the expression of TGF-beta in this model. Furthermore, in uremic animals, a low Pi diet prevented hyperparathyroidism, while a high Pi diet produced hyperplasia of the parathyroid glands (37). These data suggest that the Pi response factor TFE3 may regulate cell proliferation and matrix synthesis.

Finally, we used the yeast one-hybrid system to clone a transcription factor (TFE3) that binds to a specific sequence in the promoter of the NPT2 gene. TFE3 is known to activate transcription through the µE3 site of the immunoglobulin heavy chain enhancer. The characterization of TFE3L and TFE3S-interacting transcription factors and investigations of their regulation may provide further insights into the molecular mechanisms involved in the regulation of the NPT2 gene by dietary Pi.

    ACKNOWLEDGEMENT

We thank Dr. Calame for providing TFE3 expression vectors and mouse TFE3 antibodies.

    FOOTNOTES

* This work was supported by Grant 11557202 (to K. M.) from the Ministry of Education, Science, Sports and Culture of Japan.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Dept. of Clinical Nutrition, School of Medicine, Tokushima University, Kuramoto-Cho 3, Tokushima City 770, Japan. Tel.: 81-886-33-7095; Fax: 81-886-33-7094; E-mail: miyamoto@nutr.med.tokushima-u.ac.jp.

    ABBREVIATIONS

The abbreviations used are: Pi, inorganic phosphate; bp, base pair(s); nt, nucleotide number; PRE, phosphate response element; EMSA, electrophoretic mobility shift assay; UAS, upstream activating sequence; TFE3, mouse transcription factor µE3; GAPDH, glyceraldehye-3-phosphate dehydrogenase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Bernt, T. J., and Knox, F. G. (1992) in The Kidney: Physiology and Pathophysiology (Seldin, D. W. , and Giebisch, G., eds), 2nd Ed. , pp. 2511-2531, Raven Press, Ltd., New York
2. Murer, H., and Biber, J. (1992) in The Kidney: Physiology and Pathophysiology (Seldin, D. W. , and Giebisch, G., eds), 2nd Ed. , pp. 2481-2509, Raven Press, Ltd., New York
3. Murer, H., and Biber, J. (1996) Annu. Rev. Physiol. 58, 607-618[CrossRef][Medline] [Order article via Infotrieve]
4. Levi, M., Lotscher, M., Sorbs, V., Custer, M., Azar, M., Kaissling, B., Murer, H., and Biber, J. (1994) Am. J. Physiol. 267, F900-F908[Abstract/Free Full Text]
5. Werner, A., Kempson, S. A., Biber, J., and Murer, H. (1994) J. Biol. Chem. 269, 6637-6639[Abstract/Free Full Text]
6. Katai, K., Segawa, H., Haga, H., Morita, K., Arai, K., Tatsumi, S., Taketani, Y., Miyamoto, K., Hisano, S., Fukui, Y., and Takeda, E. (1997) J. Biochem. (Tokyo) 121, 50-55[Abstract/Free Full Text]
7. Morita, K., Fujioka, A., Haga, H., Nii, T., Segawa, H., Kouda, T., Taketani, Y., Hisano, S., Fukui, Y., Miyamoto, K., and Takeda, E. (1998) J. Bone Miner. Metab. 16, 234-240[CrossRef]
8. Lotscher, M., Wilson, P., Nguyen, S., Kaissling, B., Biber, J., and Murer, H. (1996) Kidney Int. 49, 1012-1018[Medline] [Order article via Infotrieve]
9. Taketani, Y., Segawa, H., Chikamori, M., Morita, K., Tanaka, K., Kido, S., Yamamoto, H., Iemori, Y., Tatsumi, S., Tsugawa, N., Okano, T., Kobayashi, T., Miyamoto, K., and Takeda, E. (1998) J. Biol. Chem. 273, 14575-14581[Abstract/Free Full Text]
10. Takahashi, F., Morita, K., Katai, K., Segawa, H., Fujioka, A., Kouda, T., Tatsumi, S., Nii, T., Taketani, Y., Haga, H., Hisano, S., Fukui, Y., Miyamoto, K., and Takeda, E. (1998) Biochem. J. 333, 175-181
11. Biber, J., Custer, M., Magagnin, S., Hayes, G., Lotscher, M., Kaissling, B., and Murer, H. (1996) Kidney Int. 49, 981-985[Medline] [Order article via Infotrieve]
12. Kavanaugh, M. P., and Kabat, D. (1996) Kidney Int. 49, 959-963[Medline] [Order article via Infotrieve]
13. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[Medline] [Order article via Infotrieve]
14. Vidal, M., and Legrain, P. (1999) Nucleic Acids Res. 27, 919-929[Abstract/Free Full Text]
15. Rose, M. D., Winston, F., and Hieter, P. (1990) Methods in Yeast Genetics: A Laboratory Course Manual , pp. 265-289, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
16. Taketani, Y., Miyamoto, K., Tanaka, K., Katai, K., Chikamori, M., Tatsumi, S., Segawa, H., Yamamoto, H., Morita, K., and Takeda, E. (1997) Biochem. J. 324, 927-934
17. Roman, C., Matera, A. G., Cooper, C., Artandi, S., Blain, S., Ward, D. C., and Calame, K. (1992) Mol. Cell. Biol. 12, 817-827[Abstract/Free Full Text]
18. Roman, C., Cohn, L., and Calame, K. (1991) Science 254, 94-97[Abstract/Free Full Text]
19. Arakawa, T., Nakamura, M., Yoshimoto, T., and Yamamoto, S. (1995) FEBS Lett. 363, 105-110[CrossRef][Medline] [Order article via Infotrieve]
20. Artandi, S. E., Merrell, K., Avitahl, N., Wong, K. K., and Calame, K. (1995) Nucleic Acids Res. 23, 3865-3871[Abstract/Free Full Text]
21. Demczuk, S., Habers, M., and Vennstrom, B. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 2574-2578[Abstract/Free Full Text]
22. Miura, Y., Uchijima, Y., Takahashi, S., and Noguchi, T. (1993) Biosci. Biotech. Biochem. 57, 358-359
23. Oshima, Y. (1997) Genes Genet. Syst. 72, 323-334[CrossRef][Medline] [Order article via Infotrieve]
24. Collins, J. F., Zeng, J., and Ghishan, F. K. (1997) Nutr. Res. 17, 295-304
25. Markovich, D., Verri, T., Sorribas, V., Forgo, J., Biber, J., and Murer, H. (1995) Pfluegers Arch. 430, 459-463[CrossRef][Medline] [Order article via Infotrieve]
26. Moallem, E., Kilav, R., Silver, J., and Naveh-Many, T. (1998) J. Biol. Chem. 273, 5253-5259[Abstract/Free Full Text]
27. Ogawa, N., and Oshima, Y. (1990) Mol. Cell. Biol. 10, 2224-2236[Abstract/Free Full Text]
28. Bun-Ya, M., Mishima, M., Harashima, S., and Oshima, Y. (1991) Mol. Cell. Biol. 6, 3229-3238
29. Hilfiker, H., Hartmann, C. M., Stange, G., and Murer, H. (1998) Am. J. Physiol. 274, F197-F204[Abstract/Free Full Text]
30. Norman, A. W., Roth, J., and Orchi, L. (1982) Endocr. Rev. 3, 331-366[CrossRef][Medline] [Order article via Infotrieve]
31. Tanaka, Y., and DeLuca, H. F. (1973) Arch. Biochem. Biophys. 154, 566-570[CrossRef][Medline] [Order article via Infotrieve]
32. Murayama, A., Takeyama, K., Kitanaka, S., Kodera, Y., Hosoya, T., and Kato, S. (1998) Biochem. Biophys. Res. Commun. 249, 11-16[CrossRef][Medline] [Order article via Infotrieve]
33. Shinki, T., Shimada, H., Wakino, S., Anazawa, H., Hayashi, M., Saruta, T., DeLuca, H. F., and Suda, T. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 12920-12925[Abstract/Free Full Text]
34. Weterman, M. A., Wilbrink, M., and Geurts van Kessel, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 15294-15298[Abstract/Free Full Text]
35. Hua, X., Liu, X., Ansari, D. O., and Lodish, H. (1998) Genes Dev. 12, 3084-3095[Abstract/Free Full Text]
36. Okuda, S., Nakamura, T., Rouslahti, E., and Border, W. A. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9765-9769[Abstract/Free Full Text]
37. Slatopolsky, E., Finch, J., Denda, M., Ritter, C., Zhong, M., Dusso, A., MacDonald, P. N., and Brown, A. L. (1996) J. Clin. Invest. 97, 2534-2540[Medline] [Order article via Infotrieve]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Rosenberg, C. Shachaf, M. Tzukerman, and K. Skorecki
A murine transgenic model for transcriptional regulation of the Na/Pi-IIa major renal phosphate cotransporter
Am J Physiol Renal Physiol, May 1, 2007; 292(5): F1617 - F1625.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
K. A. Conrads, M. Yi, K. A. Simpson, D. A. Lucas, C. E. Camalier, L.-R. Yu, T. D. Veenstra, R. M. Stephens, T. P. Conrads, and G. R. Beck Jr.
A Combined Proteome and Microarray Investigation of Inorganic Phosphate-induced Pre-osteoblast Cells
Mol. Cell. Proteomics, September 1, 2005; 4(9): 1284 - 1296.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Ito, Y. Sakai, M. Furumoto, H. Segawa, S. Haito, S. Yamanaka, R. Nakamura, M. Kuwahata, and K.-i. Miyamoto
Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1101 - E1109.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. H. Sugiura and R. P. Ferraris
Dietary phosphorus-responsive genes in the intestine, pyloric ceca, and kidney of rainbow trout
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R541 - R550.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Segawa, I. Kaneko, S. Yamanaka, M. Ito, M. Kuwahata, Y. Inoue, S. Kato, and K.-i. Miyamoto
Intestinal Na-Pi cotransporter adaptation to dietary Pi content in vitamin D receptor null mice
Am J Physiol Renal Physiol, July 1, 2004; 287(1): F39 - F47.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Moz, J. Silver, and T. Naveh-Many
Characterization of cis-acting element in renal NaPi-2 cotransporter mRNA that determines mRNA stability
Am J Physiol Renal Physiol, April 1, 2003; 284(4): F663 - F670.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
K.-I. Miyamoto, M. Ito, H. Segawa, and M. Kuwahata
Molecular targets of hyperphosphataemia in chronic renal failure
Nephrol. Dial. Transplant., March 1, 2003; 18(90003): iii79 - 80.
[Abstract] [Full Text] [PDF]